Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection - Wikidata - awgldk - TriplyDB

Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection

Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection

http://www.wikidata.org/entity/Q34814831

about

Probiotics for preventing urinary tract infections in adults and children Non-Antibiotic Prophylaxis for Urinary Tract Infections Anatomy and Physiology of the Urinary Tract: Relation to Host Defense and Microbial Infection Microbicides and their potential as a catalyst for multipurpose sexual and reproductive health technologies Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity Mechanisms and modifications of naturally occurring host defense peptides for anti-HIV microbicide development Gram-Positive Uropathogens, Polymicrobial Urinary Tract Infection, and the Emerging Microbiota of the Urinary Tract Characterization of the urinary microbiome in healthy dogs.Exploring a road map to counter misconceptions about the cervicovaginal microbiome and disease.Probiotics - the versatile functional food ingredients Homeostatic properties of Lactobacillus jensenii engineered as a live vaginal anti-HIV microbicide [Primary and secondary prevention of urinary tract infections].Rapid species-level identification of vaginal and oral lactobacilli using MALDI-TOF MS analysis and 16S rDNA sequencing.The advantages of second best: comment on "Lactobacilli vs antibiotics to prevent urinary tract infections"The effect of an oral probiotic containing lactobacillus, bifidobacterium, and bacillus species on the vaginal microbiota of spayed female dogs.Comparative genomics of Lactobacillus crispatus suggests novel mechanisms for the competitive exclusion of Gardnerella vaginalis.Are pathogenic bacteria just looking for food? Metabolism and microbial pathogenesis.Probiotic Properties of Lactobacillus crispatus 2,029: Homeostatic Interaction with Cervicovaginal Epithelial Cells and Antagonistic Activity to Genitourinary Pathogens.Probiotics to counteract biofilm-associated infections: promising and conflicting data Robust vaginal colonization of macaques with a novel vaginally disintegrating tablet containing a live biotherapeutic product to prevent HIV infection in women.The microbiome of the urinary tract--a role beyond infection.Antimicrobial activity and antibiotic susceptibility of Lactobacillus and Bifidobacterium spp. intended for use as starter and probiotic cultures.The yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA Probiotics in obstetrics and gynaecology.Recurrent urinary tract infections in children: Preventive interventions other than prophylactic antibiotics Characterization of bacterial isolates from the microbiota of mothers' breast milk and their infants.Hydrogen Peroxide-Producing Lactobacilli Are Associated With Lower Levels of Vaginal Interleukin-1β, Independent of Bacterial Vaginosis The subject, its biology, and the chronic recurrent cystitis.Transient microbiota exposures activate dormant Escherichia coli infection in the bladder and drive severe outcomes of recurrent disease.Diagnosis and management of recurrent urinary tract infections in non-pregnant women.Preventive effects of Lactobacillus mixture on experimental E. coli urinary tract infection in infant rats Asymptomatic Bacteriuria in Clinical Urological Practice: Preoperative Control of Bacteriuria and Management of Recurrent UTI Alternative approaches to conventional treatment of acute uncomplicated urinary tract infection in women.Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.Effects of feminine hygiene products on the vaginal mucosal biome Urinary tract infection in older adults.Dysbiosis of urinary microbiota is positively correlated with type 2 diabetes mellitus.Infection prevention and control during prolonged human space travel.Probiotics and nutrients for the first 1000 days of life in the developing world.Obstetric and gynecological diseases and complications resulting from vaginal dysbacteriosis.

P2860

Q24186954-360D68FF-7611-4C97-B0D0-91C5091AAF28 Q26752350-EEA16AAA-E9CE-43AD-9B49-C426DC87D677 Q26782602-FFD305D5-D541-409F-BB4D-FB2C526B92F1 Q27026257-A1EB2E02-C434-44C9-8EAE-9964E5B105AA Q28070349-19051C54-D2B5-443F-A83E-DB3291C6A42E Q28257799-38EB70CD-A276-4533-A0AF-4B22FD259EA3 Q28829569-A4FAD0F8-0594-41E5-8BE1-199BCAE84B1F Q33699294-7B22D0D8-30ED-4850-8450-1480F83C42E2 Q33733200-9BA9BB7D-B668-4890-9BE5-43D650E5FAFC Q34046804-A404E326-99F1-4744-BC1C-1D8ECB745077 Q34539354-88156E02-AEF8-46FD-8F68-959B66B10407 Q34632416-CC82287E-21D9-4809-BB06-33FC6558A820 Q34748556-241441AF-5C3A-423A-A2BB-6BE8BCFCA751 Q34850099-A1FC93EE-2B7F-4A7D-8FC6-D734B31A5B7D Q34986700-8365AB04-25B9-42DD-BE37-EA156D3148A2 Q34992172-87BABB05-6B53-4F36-990B-6977B560904F Q35087604-0507C2E3-E0F6-44CC-AB10-F1EFF8CC9297 Q35207445-2782461E-EEA9-438E-BDB7-69748E3E3816 Q35278680-B8A5DC40-9435-4A1A-ABC5-76241F02AB70 Q35415972-B2790E98-53AE-4CDE-B8D8-65A091EC08AD Q35544680-061C84CA-F230-4CE4-8793-1585C276140C Q35613949-D4407A85-51BE-4AB2-B86D-88D3D9C11369 Q35627540-4B7C1C27-9564-4EAF-B7E4-4C383C7BE15B Q35656116-200DB4CB-57F7-47F7-AC12-71F2A5FECF69 Q35788472-54CD5814-95AB-43A1-88F2-0AE9E9E159DC Q35884117-F53CFC0A-2043-40A1-AB5C-1699478C67BA Q35903302-1E19896F-F676-4547-98BD-121E07F86149 Q36169154-54B9E3AA-8C3C-42BE-9217-A23EE6C99B66 Q36328388-1BDC0B53-96B9-46FC-82AF-B6CA419E77AD Q36396956-63B09F64-1BF0-4014-918B-F7D129EFA368 Q36620385-B8D150F7-CB84-40AC-90EB-1F4560A56C7D Q36735387-CD3D12FB-790E-4CE6-820D-5FE82212B274 Q36754301-3201295D-E371-4CBD-8EDB-F3461FD8722D Q36951570-9D29AF26-4E43-4F7D-BE06-A4F7A433ACCD Q37136755-165088A9-9865-4812-A095-9FB3D91D4DBF Q37425374-E0EA571D-FD0C-4600-B861-6059B57C7530 Q37706108-275381B1-9C7E-439E-90D2-6AD9B8B448F8 Q38050888-532DF4C6-5C22-49D4-89A5-5B4536964949 Q38068981-FE2BF1DC-E52D-4E06-8119-14B124C71778 Q38202912-20E10CCE-2782-484B-BBFC-339581DB48B2

P2860

Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection

http://www.wikidata.org/entity/Q34814831

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Randomized, placebo-controlled ...... urrent urinary tract infection

@ast

Randomized, placebo-controlled ...... urrent urinary tract infection

@en

Randomized, placebo-controlled ...... urrent urinary tract infection

@nl

type

label

Randomized, placebo-controlled ...... urrent urinary tract infection

@ast

Randomized, placebo-controlled ...... urrent urinary tract infection

@en

Randomized, placebo-controlled ...... urrent urinary tract infection

@nl

prefLabel

Randomized, placebo-controlled ...... urrent urinary tract infection

@ast

Randomized, placebo-controlled ...... urrent urinary tract infection

@en

Randomized, placebo-controlled ...... urrent urinary tract infection

@nl

P1433

Q34814831-B35FF45E-9E49-4716-B4C0-0780EB7FCE3A

P1476

Q34814831-D4ACA999-7439-477C-B7DD-EA69899875CA

P2093

Q34814831-255F4185-9611-48BA-9CEE-C9AF50604B51

Q34814831-3502D049-517D-433C-B2C9-F5B98F45B9B8

Q34814831-3E87A623-5427-4556-B028-FF7F54B8C5B6

Q34814831-558A237F-7497-4445-BF67-2BB995B50D23

Q34814831-6C94CDCE-C018-42FE-821F-1A451B3E2006

Q34814831-755C86DA-0B65-4099-8EA1-A0A342FF7C2F

Q34814831-93EA2C40-7CF7-4371-907E-C287F2FF0D54

Q34814831-B0BF5AA9-7682-4DE1-B700-518669AA75E7

P2860

Q34814831-0F5EF4B8-2BA3-4BF6-95E6-F496BDDDF369

Q34814831-1094E7BC-8759-4CC3-A44E-F8E90680BFC5

Q34814831-23372FC5-5264-4973-9353-45E69F3C0D5D

Q34814831-2AA37C60-720D-422F-AEA0-33018473F505

Q34814831-327D07A4-15AD-47FB-AA9F-DEAA5C2EEB5A

Q34814831-3C57C223-76D0-4A2D-BFD2-30627C169DEC

Q34814831-3E6FF913-2E2D-494B-941D-A110ABDBC527

Q34814831-431E43F7-9936-4FE4-B88A-F0CD7DB6C920

Q34814831-484DFE27-2D32-4B8A-B428-5584A85A5D94

Q34814831-49E81EDE-A26C-4179-A1A9-96560E49F462

P304

Q34814831-80956C64-87E0-48BB-BFF5-A4EA02055969

P31

Q34814831-4508DD5B-EAB9-47D9-ADFF-6276B39F295A

P356

Q34814831-083BFB1D-B645-408F-A1FC-930951CA24C3

P407

Q34814831-9674910F-B0A2-4FE9-9821-953F7AB04364

P433

Q34814831-E6494B22-9C3C-47FA-82C8-3F876D2B7560

P478

Q34814831-E583BF12-CA8D-4D31-AEEA-681DD000A829

P50

Q34814831-67FDACD0-4C48-4C79-BFDD-360077AEEE2B

Q34814831-F2AF8261-39B2-45CD-B23F-25B87939150D

P577

Q34814831-920F2538-47F4-4B2D-8EEE-85AAF2D750DC

P5875

Q34814831-7167228A-DE98-4499-8104-B591E47859F7

P698

Q34814831-B035297F-56A6-454A-AD56-BB5CDD0FFD6F

P921

Q34814831-86369808-E54C-4D06-9F40-A5F40CED2653

Q34814831-963A7BC5-E714-42BF-9D31-34142F29A29D

Q34814831-B89C5256-5056-437E-9852-81F9150FE17D

P932

Q34814831-CE328B32-FB8E-489D-8B89-F0639E408EC3

P356

P1433

Clinical Infectious Diseases

P1476

Randomized, placebo-controlled ...... urrent urinary tract infection

@en

P2093

Christopher A Czaja

http://www.w3.org/2001/XMLSchema#string

Marsha Cox

http://www.w3.org/2001/XMLSchema#string

Melissa Au-Yeung

http://www.w3.org/2001/XMLSchema#string

Pacita L Roberts

http://www.w3.org/2001/XMLSchema#string

Thomas M Hooton

http://www.w3.org/2001/XMLSchema#string

Tina Fiedler

http://www.w3.org/2001/XMLSchema#string

Walter E Stamm

http://www.w3.org/2001/XMLSchema#string

Yuliya Yarova-Yarovaya

http://www.w3.org/2001/XMLSchema#string

P2860

Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis

The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species

Factors Associated with Acquisition of, or Persistent Colonization by, Vaginal Lactobacilli: Role of Hydrogen Peroxide Production

Evaluation of and antimicrobial therapy for recurrent urinary tract infections in women.

Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women.

Identification of and hydrogen peroxide production by fecal and vaginal lactobacilli isolated from Japanese women and newborn infants.

Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections.

Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review.

Is there a role for lactobacilli in prevention of urogenital and intestinal infections?

Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem.

P304

1212-1217

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIR183

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

Ann E. Stapleton

David N Fredricks

P577

2011-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51056278

http://www.w3.org/2001/XMLSchema#string

P698

21498386

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

P932

3079401

http://www.w3.org/2001/XMLSchema#string